Join to View Full Profile
505 Parnassus AveSan Francisco, CA 94143
Phone+1 415-353-8728
Fax+1 415-353-2765
Dr. Farrand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2010 - 2013
Columbia University Vagelos College of Physicians and SurgeonsClass of 2010
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine
Certifications & Licensure
CA State Medical License 2015 - 2027
NY State Medical License 2012 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Publications & Presentations
PubMed
- Incidence, Prevalence, and Mortality of Interstitial Lung Diseases in Alberta, Canada: A Population-based Study.Kerri A Johannson, Zhaoyu Liu, Danielle A Southern, Meena Kalluri, Andrea S Gershon
Annals of the American Thoracic Society. 2025-03-11 - 1 citationsDifferences in Health Care and Palliative Care Use at the End of Life: A Comparison Study Among Lung Cancer, COPD, and Idiopathic Pulmonary Fibrosis.Angela O Suen, Kara Bischoff, Anand S Iyer, Keerthana Radhakrishnan, Cynthia Fenton
Chest. 2024-12-01 - 2 citationsPhage Immunoprecipitation-Sequencing Reveals CDHR5 Autoantibodies in Select Patients With Interstitial Lung Disease.Vaibhav Upadhyay, Young Me Yoon, Sara E Vazquez, Tania E Velez, Kirk D Jones
ACR Open Rheumatology. 2024-09-01
Press Mentions
Doris Duke Charitable Foundation Announces the 2022 Clinical Scientist Development AwardeesAugust 9th, 2022
Grant Support
- Remote Evaluation and Surveillance of Patients with Interstitial Lung Disease (RESPOND-ILD): Transforming ILD Care Delivery with Remote MonitoringUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
